Niagen Bioscience (OCD1) Revenue

2 Followers

Niagen Bioscience Revenue

Niagen Bioscience had a revenue of 29.79M in the quarter ending Jun 30, 2026, with -5.37%. This bring the company's revenue in the last twelve months to 129.08M, Increased -1.02%. In the fiscal year ending Dec 31, 2025, Niagen Bioscience had annual revenue of 129.42M with 29.95% growth.

Revenue (ttm)

129.08M

Revenue Growth

3.43%

P/S Ratio

1.63

Revenue/Employee

€1,106,179

Employees

117

Market Cap

€210.73M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	129.42M	29.83M	+29.95%
Dec 31, 2024	99.60M	16.03M	+19.18%
Dec 31, 2023	83.57M	11.52M	+15.99%
Dec 31, 2022	72.05M	4.60M	+6.82%
Dec 31, 2021	67.45M	8.19M	+13.82%
Dec 31, 2020	59.26M	12.97M	+28.01%
Dec 31, 2019	46.29M	14.73M	+46.69%
Dec 31, 2018	31.56M	10.36M	+48.85%
Dec 31, 2017	21.20M	―	―